SBIR/STTR Research Award
SBIR TOPIC 107 MONOCLONAL ANTIBODIES FOR THE IMMUNE TARGETS OF SWINE
Award amount
$600,000Program and phase
SBIR · Phase IAward year
2022Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- QOOLABS INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- K7HZKKAMVHK5
- Solicitation number
- PHS-2022-1
- Topic code
- 107
Research abstract
Swine is a useful animal model for studying human health and diseases. Particularly, swine is currently preferred candidate species as the source animal for xenotransplantation. However, the usefulness of pig for biomedical research has been constrained by the lack of reagents targeting immune markers involved in tissue/organ rejection. The objectives of this proposal are to generate rabbit monoclonal antibodies to selected swine immune markers that are related to xenotransplantation and to characterize the produced antibodies to demonstrate their reactivity with the appropriate swine immune cell subsets. Successful production of these antibodies will generate useful tools to promote pre-clinical biomedical research especially xenotransplantation investigations.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- AFFINITY REAGENTS FOR THE IMMUNE SYSTEM OF GUINEA PIGS IL1B, IL2, IL4, IL6, IL8, IL10, IL12, AND IL13.
- SBIR Topic 133: Development of a Serological Test for Herpes Simplex Types 1 and 2 Infections
- Affinity Reagents for the Immune System of Golden Hamster (for SARS-CoV-2 induced long-COVID disease)
- SBIR TOPIC 107 AFFINITY REAGENTS FOR THE IMMUNE SYSTEM OF GOLDEN HAMSTER
- Rapid at-home Detection for Serologic Status of Hepatitis C Virus (HCV) Infection
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Safe-OPTION: Optical Physiology To Interrogate Oligonucleotide Neurotoxicity
- A Digital Biomarker for ALS - Pison Neural Biosensor
- Preclinical Efficacy and Safety Evaluation of Oral AST-004 for Moderate Traumatic Brain Injury (TBI)
- Development of a novel oral brain penetrant therapeutic for ALS disease
- Engineering a Middle Meningeal Artery Embolization Model with Hydrophilicity and Hydraulic Resistance
Research funding history
16 SBIR/STTR records share this UEI (2014–2025). Reported award amounts total $7,488,575. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services